ATE421874T1 - Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens - Google Patents

Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens

Info

Publication number
ATE421874T1
ATE421874T1 AT98953702T AT98953702T ATE421874T1 AT E421874 T1 ATE421874 T1 AT E421874T1 AT 98953702 T AT98953702 T AT 98953702T AT 98953702 T AT98953702 T AT 98953702T AT E421874 T1 ATE421874 T1 AT E421874T1
Authority
AT
Austria
Prior art keywords
inflammatory agent
nitrogen monoxide
inhaled nitrogen
inhaled
monoxide
Prior art date
Application number
AT98953702T
Other languages
English (en)
Inventor
Warren Zapol
Kenneth Bloch
Anthony Rosenzweig
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26742873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE421874(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE421874T1 publication Critical patent/ATE421874T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
AT98953702T 1997-10-21 1998-10-19 Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens ATE421874T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6292697P 1997-10-21 1997-10-21
US08/971,003 US6656452B1 (en) 1997-10-21 1997-11-14 Use of inhaled NO as anti-inflammatory agent

Publications (1)

Publication Number Publication Date
ATE421874T1 true ATE421874T1 (de) 2009-02-15

Family

ID=26742873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953702T ATE421874T1 (de) 1997-10-21 1998-10-19 Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens

Country Status (13)

Country Link
US (2) US6656452B1 (de)
EP (1) EP1073416B1 (de)
JP (1) JP2003532615A (de)
AR (1) AR015973A1 (de)
AT (1) ATE421874T1 (de)
AU (1) AU751853B2 (de)
CA (1) CA2309038C (de)
CY (1) CY1110228T1 (de)
DE (1) DE69840526D1 (de)
DK (1) DK1073416T3 (de)
ES (1) ES2319240T3 (de)
PT (1) PT1073416E (de)
WO (1) WO1999020251A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
US20030070674A1 (en) * 2001-10-12 2003-04-17 Bryan Perry Use of aerosolized compounds in the treatment of exercise induced pulmonary hemorrhage in an equine
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US7086397B2 (en) * 2002-02-16 2006-08-08 Graham Lindley Spruiell Patient usable emergency medical kit
WO2003101276A2 (en) * 2002-05-22 2003-12-11 Virginia Commonwealth University Protective effects of pde-5 inhibitors
EP1515731A1 (de) * 2002-06-12 2005-03-23 Air Liquide Deutschland GmbH Xenonhaltiges spasmolytikum
CN1674942A (zh) * 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
JP5564158B2 (ja) * 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
WO2005077005A2 (en) * 2004-02-04 2005-08-25 The General Hospital Corporation Enhancing the effectiveness of an inhaled therapeutic gas
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
US7829097B2 (en) * 2006-02-06 2010-11-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of HMGB1 for protection against ischemia reperfusion injury
EP2514473A1 (de) * 2006-11-07 2012-10-24 The General Hospital Corporation Vorrichtung zur Zuführung von Stickoxid
WO2008132239A1 (en) 2007-04-30 2008-11-06 Nnoxe Pharmaceutiques Inc Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
WO2010049423A1 (en) * 2008-10-27 2010-05-06 Life Sciences Research Partners Vzw Effects of nitric oxide inhalation on long-term myocardial reperfusion injury
NO2440239T3 (de) 2009-06-09 2018-02-10
JP5581500B2 (ja) 2010-03-10 2014-09-03 学校法人北里研究所 虚血再灌流障害軽減用治療剤および治療装置
CA2819854A1 (en) * 2010-12-03 2012-06-07 Geno Llc Nitric oxide treatments
EP3650408A1 (de) 2011-10-03 2020-05-13 NitricGen, Inc. Vorrichtung und verfahren zur erzeugung von stickoxid in kontrollierten und genauen mengen
JP6389125B2 (ja) 2011-11-07 2018-09-12 ザ ジェネラル ホスピタル コーポレイション 赤血球の処理法
JP2014141536A (ja) * 2014-05-16 2014-08-07 Kitasato Institute 虚血再灌流障害軽減用治療剤および治療装置
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2023190532A1 (ja) * 2022-03-29 2023-10-05 康太郎 木田 横紋筋融解症を治療するための医薬組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536241A (en) 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
EP1875917A3 (de) * 1990-12-05 2012-11-28 The General Hospital Corporation Gasmischung zur Behandlung von Lungengefässverengung
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5427797A (en) 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
GB9320978D0 (en) 1993-10-12 1993-12-01 Higenbottam Timohy W Nitric oxide treatment
JPH09508097A (ja) 1993-11-02 1997-08-19 アメリカ合衆国 虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用
US5521191A (en) 1994-10-17 1996-05-28 Washington University Method for treatment of arterial stenosis
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5725492A (en) * 1996-03-04 1998-03-10 Cormedics Corp Extracorporeal circulation apparatus and method
ES2267141T3 (es) 1996-04-05 2007-03-01 The General Hospital Corporation Tratamiento de una hemoglobinopatia.
US6601580B1 (en) 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation

Also Published As

Publication number Publication date
WO1999020251A1 (en) 1999-04-29
EP1073416A1 (de) 2001-02-07
DE69840526D1 (de) 2009-03-19
AR015973A1 (es) 2001-05-30
AU751853B2 (en) 2002-08-29
CY1110228T1 (el) 2015-01-14
US6656452B1 (en) 2003-12-02
AU1101299A (en) 1999-05-10
EP1073416A4 (de) 2004-07-07
ES2319240T3 (es) 2009-05-05
US6811768B2 (en) 2004-11-02
CA2309038A1 (en) 1999-04-29
US20040096523A1 (en) 2004-05-20
DK1073416T3 (da) 2009-03-09
JP2003532615A (ja) 2003-11-05
CA2309038C (en) 2009-04-21
PT1073416E (pt) 2009-03-17
EP1073416B1 (de) 2009-01-28

Similar Documents

Publication Publication Date Title
ATE421874T1 (de) Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens
ATE202347T1 (de) Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
ATE277895T1 (de) 4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
EP1047426A4 (de) Verwendung von methylnaltrexon und verwandten verbindungen
DE69629721D1 (de) Carnamoyloxy derivate von mutilin und deren verwendung als antibakterielles mittels
DE69734149D1 (de) Cinoline derivate und verwendung als heilmittel
DE69926154D1 (de) Pyridin-3-carbonsäurederivate und ihre Verwendung als Zwischenprodukte
DE59809178D1 (de) Doppelseitiges Klebeband und seine Verwendung
FR2764985B1 (fr) Detecteur electrochimique d'oxygene
DE59708471D1 (de) Stabilisierung von Metallkonjugaten
DE69825288D1 (de) Prodrugs und konjugate von selenolenthaltenden verbindungen und ihre verwendung
DE69513307D1 (de) Zusammensetzung und verwendung
DE69907146T2 (de) Direkte oxidation von cycloalkanen
DE69811223D1 (de) N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonisten
DE69801878D1 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
DE69808266D1 (de) Herstellung und verwendung von alpha-ketoamid derivate und anordnunge
DE69510228D1 (de) Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel
DE69717647D1 (de) 3-mercaptoacetylamino-1,5-substituierte-2-oxo-azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
ID17406A (id) Benda-benda penyerap berpori
NO996545D0 (no) Behandling av aluminiumslagg
DE69821988D1 (de) Substituierte isochinoline derivate und ihre verwendung als anticonvulsiva
DE69832902D1 (de) Oromukosal-zytokin-zusammensetzungen und ihre verwendung
DE59708755D1 (de) Verwendung von 3-Acylthiohexylestern als Aroma- und Riechstoffe
DE59702428D1 (de) Verwendung von hydroxycarbonsäureestern als verdickungsmittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1073416

Country of ref document: EP